NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $397,000 | 0.0% | 4,695 | 0.0% | 0.16% | 0.0% |
Q2 2022 | $397,000 | +58.2% | 4,695 | +63.8% | 0.16% | +75.6% |
Q1 2022 | $251,000 | 0.0% | 2,867 | 0.0% | 0.09% | 0.0% |
Q4 2021 | $251,000 | +4.1% | 2,867 | -2.6% | 0.09% | -10.9% |
Q3 2021 | $241,000 | -2.0% | 2,944 | +9.0% | 0.10% | -9.0% |
Q2 2021 | $246,000 | +6.5% | 2,701 | -0.0% | 0.11% | -5.1% |
Q1 2021 | $231,000 | -2.5% | 2,702 | +7.6% | 0.12% | -7.1% |
Q4 2020 | $237,000 | -14.4% | 2,512 | -21.0% | 0.13% | -28.4% |
Q3 2020 | $277,000 | +3.4% | 3,180 | +3.5% | 0.18% | -4.3% |
Q2 2020 | $268,000 | +17.0% | 3,073 | +10.9% | 0.18% | -13.6% |
Q1 2020 | $229,000 | -2.6% | 2,772 | +11.6% | 0.21% | +17.7% |
Q4 2019 | $235,000 | +10.8% | 2,483 | +1.8% | 0.18% | -3.7% |
Q3 2019 | $212,000 | -2.3% | 2,439 | +2.7% | 0.19% | -6.0% |
Q2 2019 | $217,000 | -8.1% | 2,374 | -3.3% | 0.20% | -14.5% |
Q1 2019 | $236,000 | +88.8% | 2,455 | +69.9% | 0.23% | +134.0% |
Q4 2018 | $125,000 | – | 1,445 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |